Google Alert - diet

News 1 new result for diet

Orexigen slates diet-pill trial, shares jump Reuters Wall Street has also had to scale back initial high hopes for another experimental diet drug pill, Arena Pharmaceuticals Inc's (ARNA.O) lorcaserin. The FDA rejected the product last October due to safety concerns. Shares of Orexigen rose to $2.52, ... See all stories on this topic »

---

Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.